Showing results (3071-3080 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|August 8, 2019
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting SystemEmanuel Raschi, Ippazio Cosimo Antonazzo, Michelangelo La Placa, et al.
The Oncologist|August 24, 2019
Outcomes in Patients Treated with Laser Interstitial Thermal Therapy for Primary Brain Cancer and Brain MetastasesLeigh Klaus Swartz, Katherine G Holste, Michelle M Kim, et al.
The Oncologist|August 3, 2019
Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic ImplicationsJiwon Koh, Keun-Wook Lee, Soo Kyung Nam, et al.
The Oncologist|August 3, 2019
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western PopulationsChing-Hsuan Chen, Yen-Shen Lu, Ann-Lii Cheng, et al.
The Oncologist|September 15, 2022
Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled TrialSriram Yennurajalingam, Ahsan Azhar, Zhanni Lu, et al.
The Oncologist|October 6, 2022
Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic ProgramsZhonglin Hao, Saurabh Parasramka, Quan Chen, et al.
The Oncologist|October 9, 2022
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus AvelumabCharlotte Manogue Hawkins, Pedro C Barata, Patrick Cotogno, et al.
The Oncologist|October 10, 2022
Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident VaricesWei-Li Ma, Dwan-Ying Chang, Ching-Hung Lin, et al.
The Oncologist|October 10, 2022
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical TrialsGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
The Oncologist|October 3, 2022
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2Richard S Finn, Thomas Yau, Chih-Hung Hsu, et al.
Pageof 571